Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Raphael Brandao Moreira"'
Autor:
Raphael Brandao Moreira, Mauricio Fernandes, Mariana Ribeiro Monteiro, Francine Maria Agostinho Luiz, Erika Simplicio Silva, Perla de Mello Andrade, Mayara Batista Pinto, Letycia Lima, Astrid Silva, Juliana Nunez, Daniele Freitas, Luiz Henrique de Lima Araujo, Caio Vinicius Teles Rossini, Pedro Nazareth Aguiar
Publikováno v:
Frontiers in Urology. 2
Previous studies suggested that obesity pro-inflammatory state could improve immune checkpoint inhibitors (ICI) clinical efficacy. This is a retrospective, multicenter, and observational study that included patients treated in a private Brazilian Onc
Autor:
Toni K. Choueiri, Paul L. Nguyen, Guillermo de Velasco, Ayal A. Aizer, Allison Martin, Maxine Sun, Priscilla K. Brastianos, Quoc-Dien Trinh, Raphael Brandao Moreira
Publikováno v:
European Urology Focus. 5:474-481
Background The incidence of brain metastases (BM) in patients with renal cell carcinoma (RCC) is hypothesized to have increased in the last 2 decades. Objective To define incidence trends according to patient and clinical characteristics, to identify
Autor:
Takeshi Yuasa, Daniel Y.C. Heng, Steven Yip, Christina Canil, Lori Wood, Camillo Porta, Benoit Beuselinck, Naveen S. Basappa, Sandy Srinivas, Alexander Wong, Brian I. Rini, Ravindran Kanesvaran, D. Scott Ernst, Simon Yuen Fai Fu, Hao-Wen Sim, Connor Wells, Toni K. Choueiri, Raphael Brandao Moreira, Anil Kapoor
Publikováno v:
Cancer. 124:3677-3683
BACKGROUND To the authors' knowledge, outcomes and prognostic tools have yet to be clearly defined in patients with metastatic renal cell carcinoma (mRCC) who are treated with immuno-oncology (IO) checkpoint inhibitors (programmed death-ligand 1 [PD-
Autor:
Fabiano Rubião Lucchesi, Jean Milani, Daniela Pezzutti Domingues Armentano, Raphael L. C. Araujo, Raphael Brandao Moreira, Luís Antônio de Castro, Gustavo S F Pinto
Publikováno v:
Journal of surgical oncologyREFERENCES. 121(5)
The mainstays of treatment for colorectal liver metastases (CRLMs) are surgery and chemotherapy. Chemotherapeutic benefits of tumor shrinkage and systemic control of micrometastases are in part counterbalanced by chemotoxicity that can modify the liv
Autor:
Raphael Brandao Moreira, Ronit Simantov, Xun Lin, Lana Hamieh, Rana R. McKay, Toni K. Choueiri
Publikováno v:
Kidney Cancer. 2:37-46
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) have demonstrated an anti-tumorigenic effect in several cancers. However, their use is associated with an increased risk in renal cell carcinoma (RCC) and their effect has not been assessed i
Autor:
Christopher Sweeney, Dominick Bossé, Wanling Xie, Lauren C. Harshman, Gustavo Ruiz Ares, Raphael Brandao Moreira, Toni K. Choueiri
Publikováno v:
Cancer. 124:925-933
Background Overall survival (OS) is a critical endpoint in adjuvant trials but requires long durations to events and significant patient resources. In the current study, the authors assessed whether disease-free survival (DFS) can be an early clinica
Autor:
Rana R. McKay, Raphael Brandao Moreira, Toni K. Choueiri, Lana Hamieh, Ronit Simantov, Xun Lin
Publikováno v:
Clinical Genitourinary Cancer. 15:221-229
Introduction Observational studies have suggested that metformin use is associated with favorable outcomes in several cancers. For renal cell carcinoma (RCC), data have been limited. Therefore, we investigated the effect of metformin on survival in m
Autor:
Paulo Ricardo Santos Nunes Filho, Raphael Brandao Moreira, Andre P. Fay, Caroline Albuquerque, Carlos H. Barrios
Publikováno v:
Repositório Institucional PUCRS
Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron:PUC_RS
Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron:PUC_RS
Submitted by Biblioteca Suporte PUCRS (biblioteca.suporte@pucrs.br) on 2022-05-17T19:51:53Z No. of bitstreams: 2 The_Management_of_Immunerelated_Adverse_Events_Associated_with_Immune_Checkpoint_Blockade.pdf: 1038544 bytes, checksum: e8a15ed773d7b1c62
Autor:
Erika Simplicio, Daniele Freitas, Mayara Batista, Raphael Brandao Moreira, Francine Luiz, Mariana Ribeiro Monteiro, Pedro Nazareth Aguiar, Perla de Mello Andrade, Mauricio Fernandes, Astrid Silva, Juliana Nunez, Luiz H. Araujo, Letycia Lima
Publikováno v:
Journal of Clinical Oncology. 38:e15066-e15066
e15066 Background: Obesity is linked to an increased risk of cancer development. The excess of body fatness seems to be associated with alterations in hormonal, metabolic and inflammatory pathways, that may lead to activation of the carcinogenesis pr
Autor:
Marcelo Rocha Cruz, Raphael Brandao Moreira, Matheus Bongers Alessandretti, Antonio C. Buzaid
Publikováno v:
Cancer Research. 75:P3-13
INTRODUCTION Cancer biology is characterised by genomic alterations. There is an ongoing revolution in cancer research due to the emergence of novel technologies based on next generation sequencing (NGS). OBJECTIVES To identify abnormalities in indiv